MOLECULIN BIOTECH INC (MBRX) Stock Analyst Ratings
NASDAQ:MBRX - US60855D3098 - Common Stock
0.3612 USD
-0.01 (-3.81%)
ChartMill assigns a Buy % Consensus number of 82% to MBRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.14. This target is 1876.74% above the current price.
MBRX was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MBRX.
In the previous month the buy percentage consensus was at a similar level.
MBRX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-25 | Maxim Group | Upgrade | Hold -> Buy |
| 2025-03-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-12 | Maxim Group | Maintains | Buy -> Buy |
| 2024-04-12 | Roth MKM | Maintains | Buy -> Buy |
| 2024-03-26 | Maxim Group | Maintains | Buy -> Buy |
| 2023-12-14 | HC Wainwright & Co. | Initiate | Buy |
| 2023-04-18 | Roth MKM | Maintains | Buy |
| 2023-03-24 | Oppenheimer | Reiterate | Outperform |